drugset / Trial / NCT00553072

Magnesium Sulphate in Perinatal Asphyxia

NCT00553072

Phase 3 Completed 40 enrolled Sheri Kashmir Institute of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

Magnesium sulphate has been shown to be neuroprotective. The investigators hypothesize that magnesium sulphate infusion given to babies with perinatal asphyxia should improve outcome in the immediate neonatal period.

Timeline

Start
2004-09
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 250 mg/kg

Indications